GlaxoSmithKline

Greek digital consultancy and market research firm Convert Group reported a 103 percent jump in revenues in the first half of the year, compared with the same period in 2017.

The company said it estimates that this growth rate will be sustained until the end of the year, with turnover set to reach 1.3 million euros.

Swiss pharmaceuticals giant Novartis announced on March 27 it will sell its stake in its consumer healthcare joint venture to Britain's GlaxoSmithKline for $13 billion (10.4 billion euros).

The British government has rekindled its industrial strategy, unveiled earlier this year to prepare the economy for Brexit, with plans to boost the country's pharmaceuticals sector via fresh investments and public-private collaborations.

GlaxoSmithKline is cutting the price charged for its pneumococcal vaccine when given to refugees, following complaints about the product's "exorbitant" cost by medical charity Medecins Sans Frontieres.

GlaxoSmithKline is cutting the price charged for its pneumococcal vaccine when given to refugees, following complaints about the product's "exorbitant" cost by medical charity Medecins Sans Frontieres.

The world?s first malaria vaccine got a green light on July 24 from European drugs regulators who recommended it should be licensed for use in babies in Africa at risk of the mosquito-borne disease. 

The first large-scale trial of an Ebola vaccine will begin in Guinea at the weekend, the World Health Organization said March 5, weeks after a similar test kicked off in neighbouring Liberia.
      

Human tests of two possible Ebola vaccines have proven safe and efficacy tests will begin within weeks in the three west African countries ravaged by the deadly virus, the World Health Organization said Jan. 9.
      

Global aid agency Doctors Without Borders said on Nov. 13 it would begin unprecedented trials within a month on Ebola drugs and blood from survivors using patients in west Africa.
      
The trials in Guinea are aimed at rushing out an emergency therapy to battle an epidemic which has taken more than 5,000 lives since December.
      

Ebola-hit nations met for crisis talks on Thursday as the death toll topped 1,500 and the World Health Organization warned that the number of cases could exceed 20,000 before the outbreak is stemmed.